Daniel S. Grau

Daniel S.
Grau was the founder of Sojournix, Inc. (founded in 2016) where he held the title of President, Chief Executive Officer & Director.
He is currently the President, CEO, Secretary, Treasurer & Director at Theriana Pharmaceuticals, Inc., Chairman at Lusaris Therapeutics, Inc., and Director at AbCellera Boston, Inc. (since 2019).
In his former positions, he served as Vice Chairman & Chief Executive Officer at Cortria Corp., President & Chief Executive Officer at Avilar Therapeutics, Inc., and Director at Concert Pharmaceuticals, Inc. He was also a Director at Therapeutics Acquisition Corp.
and President at Nxera Pharma UK Ltd. Additionally, he worked as the Chief Operating Officer at CombinatoRx, Inc. from 2001 to 2008 and as a Management Consultant at Pharmacia Corp.
Mr. Grau completed his undergraduate degree at Davidson College and his graduate degree at Yale University.